The identity is the easy part. The rollout is the project.
Pharmaceutical rebrand rollout across every market and touchpoint a new identity has to reach: sequencing that avoids a visible gap where the old and new brand overlap, and coordination across markets that cannot all switch on the same day.
A new identity is a deliverable; a rollout is a project with dependencies, regulatory approval timelines that differ by market, and physical assets like packaging that cannot be changed overnight. Most rebrand problems we are called in to fix are rollout failures, not design failures.
A rollout plan sequencing every touchpoint and market, a transition strategy for the overlap period, coordination with regulatory approval timelines, and execution support across the priority touchpoints.
We plan the sequencing and provide production-ready assets so your existing packaging and print suppliers can execute without guesswork. The physical production runs stay with the partners who already know your lines.
The scale our pharmaceutical rebrand rollout work has operated at.
The bottleneck differs by company. Pharmaceutical rebrand rollout starts from that bottleneck.
What comes up when planning a multi-market rebrand rollout.
It depends almost entirely on your slowest regulatory approval market and how quickly existing physical inventory depletes, rather than on design or production speed, which are rarely the bottleneck. We build the real timeline from those two constraints, rather than promising a launch date before we know them with any confidence.
Yes, and for most multi-market companies that staggered switch is unavoidable given differing regulatory approval timelines. The transition strategy exists specifically to make that stagger look deliberate and planned rather than inconsistent, with clear rules for which materials can carry old and new branding at once.
No, we provide the specifications and sequencing that packaging production follows. Physical production itself runs through your existing packaging suppliers, and we coordinate with them directly on timing so the rollout sequence and their production schedule stay aligned rather than working from separate, unsynchronised calendars that risk a mismatch.
Rollout planning can start in parallel with the final stages of identity development. See brand identity for that process, since sequencing and inventory questions depend on markets and approval timelines rather than on the final visual details, which can follow once they are confirmed and locked.
Rollout work follows brand and corporate identity projects directly. These are the related services.
A new identity ready to launch, or a rollout already underway and losing coherence. Tell us your markets and we will tell you how we would approach the pharmaceutical rebrand rollout.